These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18650033)

  • 1. Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence.
    Jatlow P; Toll BA; Leary V; Krishnan-Sarin S; O'Malley SS
    Drug Alcohol Depend; 2008 Dec; 98(3):203-9. PubMed ID: 18650033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial.
    Nanovskaya TN; Oncken C; Fokina VM; Feinn RS; Clark SM; West H; Jain SK; Ahmed MS; Hankins GDV
    Am J Obstet Gynecol; 2017 Apr; 216(4):420.e1-420.e9. PubMed ID: 27890648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Extended Pre Quit Bupropion Aid in Extinguishing Smoking Behavior?
    Hawk LW; Ashare RL; Rhodes JD; Oliver JA; Cummings KM; Mahoney MC
    Nicotine Tob Res; 2015 Nov; 17(11):1377-84. PubMed ID: 25589680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
    Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable sensitivities of urine cotinine and breath carbon monoxide at follow-up time points of three months or more in a smoking cessation trial.
    Fritz M; Wallner R; Grohs U; Kemmler G; Saria A; Zernig G
    Pharmacology; 2010; 85(4):234-40. PubMed ID: 20299823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia.
    Tidey JW; Rohsenow DJ; Kaplan GB; Swift RM; Reid N
    Psychopharmacology (Berl); 2011 Sep; 217(2):279-87. PubMed ID: 21475970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of sustained-release bupropion and placebo for smoking cessation.
    Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
    N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting smoking cessation. Who will quit with and without the nicotine patch.
    Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
    JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Seventy-five cases in which serum concentrations of cotinine were monitored prior to nicotine replacement therapy for smoking cessation].
    Tsuji T; Nagai A
    Nihon Kokyuki Gakkai Zasshi; 2007 Jan; 45(1):3-7. PubMed ID: 17313019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference.
    Cropsey KL; Trent LR; Clark CB; Stevens EN; Lahti AC; Hendricks PS
    Nicotine Tob Res; 2014 Oct; 16(10):1348-55. PubMed ID: 24891552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
    Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
    JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of expired air carbon monoxide: effect of ethnicity and relationship with saliva cotinine and nicotine.
    Berlin I; Radzius A; Henningfield JE; Moolchan ET
    Nicotine Tob Res; 2001 Nov; 3(4):325-31. PubMed ID: 11694199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
    Jorenby DE; Leischow SJ; Nides MA; Rennard SI; Johnston JA; Hughes AR; Smith SS; Muramoto ML; Daughton DM; Doan K; Fiore MC; Baker TB
    N Engl J Med; 1999 Mar; 340(9):685-91. PubMed ID: 10053177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial incentives to promote extended smoking abstinence in opioid-maintained patients: a randomized trial.
    Sigmon SC; Miller ME; Meyer AC; Saulsgiver K; Badger GJ; Heil SH; Higgins ST
    Addiction; 2016 May; 111(5):903-12. PubMed ID: 26638126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bupropion sustained-release on cigarette craving after smoking cessation.
    Durcan MJ; Deener G; White J; Johnston JA; Gonzales D; Niaura R; Rigotti N; Sachs DP
    Clin Ther; 2002 Apr; 24(4):540-51. PubMed ID: 12017399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT).
    Haustein KO; Krause J; Haustein H; Rasmussen T; Cort N
    Int J Clin Pharmacol Ther; 2004 Feb; 42(2):83-92. PubMed ID: 15180168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo controlled trial of bupropion for smoking cessation in schizophrenia.
    George TP; Vessicchio JC; Termine A; Bregartner TA; Feingold A; Rounsaville BJ; Kosten TR
    Biol Psychiatry; 2002 Jul; 52(1):53-61. PubMed ID: 12079730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous cigarette brand switching: consequences for nicotine and carbon monoxide exposure.
    Lynch CJ; Benowitz NL
    Am J Public Health; 1987 Sep; 77(9):1191-4. PubMed ID: 3618852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.